[The clinical evaluation of hochuekkito for symptoms of malignant neoplasm patients].
Hochuekkito was administered in 2.5 g doses three times a day to 162 patients who complained of anorexia or lassitude because of genitourinary cancer. The efficacy rate was 63.0%. The rate of effectiveness on anorexia was 48.4% and that on lassitude was 36.6%. Side effects were observed in 12 patients (7.4%), but most of them were mild gastrointestinal disorders. No severe adverse effects were noted.
Kuroda
M
M
Kotake
T
T
Sonoda
T
T
Maekawa
M
M
Okajima
E
E
Okawa
T
T
Ikoma
F
F
Kurita
T
T
Nakamura
T
T
Itatani
H
H
D000328:Adult; D000368:Aged; D000855:Anorexia / Q000188:drug therapy*; D005221:Fatigue / Q000188:drug therapy*; D001068:Feeding and Eating Disorders / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008518:Medicine, East Asian Traditional; D008875:Middle Aged; D010166:Palliative Care; D010936:Plant Extracts / Q000627:therapeutic use; D014565:Urogenital Neoplasms / Q000150:complications*
D010936:Plant Extracts